肝细胞癌的异质性:从机制到临床影响
Fatema Safri1, Romario Nguyen1, Shadi Zerehpooshnesfchi1
1Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, 2145, Australia.
Cancer gene therapy
|March 19, 2024
概括
瘤异质性,特别是内异质性,驱动肝细胞癌 (HCC) 治疗耐药性和复发. 了解其分子基础是改善HCC诊断和治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的原发性肝癌,治疗疗效有限.
- 早期检测挑战和耐药性导致HCC的不良结果.
- 瘤异质性,特别是内异质性,是HCC治疗失败和复发的重要驱动因素.
研究的目的:
- 审查HCC中瘤异质性的分子维度,重点关注瘤内异质性.
- 评估瘤异质性对HCC诊断和治疗策略的影响.
- 探索适合的临床前模型来研究HCC中的瘤异质性.
主要方法:
- 关于导致瘤异质性的分子机制的文献综述.
- 分析内异质性对HCC进展和治疗反应的影响.
- 评估用于研究HCC瘤异质性的临床前模型.
主要成果:
- 瘤异质性显著复杂化HCC诊断和治疗,导致治疗耐药性.
- 内异质性在HCC的晚期诊断和治疗失败中发挥着关键作用.
- 识别和描述异质性的分子驱动因素对于开发有效的HCC疗法至关重要.
结论:
- 更深入地了解瘤异质性的分子机制对于推进HCC治疗至关重要.
- 向瘤异质性是克服HCC治疗耐药性的有希望的途径.
- 需要使用适当的临床前模型进行进一步的研究,以阐明和打击HCC瘤异质性.
更多相关视频
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
36.1K
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.2K
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K